{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T12:17:52Z","timestamp":1793449072089,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T00:00:00Z","timestamp":1551139200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s10549-019-05169-0","type":"journal-article","created":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T01:58:12Z","timestamp":1551232692000},"page":"267-276","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["The effect of scalp cooling on CIA-related quality of life in breast cancer patients: a systematic review"],"prefix":"10.1007","volume":"175","author":[{"given":"Dustin H.","family":"Marks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Phillip","family":"Okhovat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Hagigeorges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athena J.","family":"Manatis-Lornell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Isakoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario E.","family":"Lacouture","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7813-520X","authenticated-orcid":false,"given":"Maryanne M.","family":"Senna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,26]]},"reference":[{"key":"5169_CR1","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1002\/pon.3531","volume":"23","author":"EK Choi","year":"2014","unstructured":"Choi EK, Kim I-R, Chang O et al (2014) Impact of chemotherapy-induced alopecia distress on body image, psychosocial well-being, and depression in breast cancer patients. Psychooncology 23:1103\u20131110. https:\/\/doi.org\/10.1002\/pon.3531","journal-title":"Psychooncology"},{"key":"5169_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-018-4983-8","author":"K Smetanay","year":"2018","unstructured":"Smetanay K, Junio P, Fei\u00dft M et al (2018) COOLHAIR: a prospective randomized trial to investigate the efficacy and tolerability of scalp cooling in patients undergoing (neo)adjuvant chemotherapy for early breast cancer. Breast Cancer Res Treat. https:\/\/doi.org\/10.1007\/s10549-018-4983-8","journal-title":"Breast Cancer Res Treat"},{"key":"5169_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.clbc.2017.07.012","volume":"18","author":"HS Rugo","year":"2018","unstructured":"Rugo HS, Voigt J (2018) Scalp hypothermia for preventing alopecia during chemotherapy. A systematic review and meta-analysis of randomized controlled trials. Clin Breast Cancer 18:19\u201328. https:\/\/doi.org\/10.1016\/j.clbc.2017.07.012","journal-title":"Clin Breast Cancer"},{"key":"5169_CR4","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1001\/jama.2016.20939","volume":"317","author":"J Nangia","year":"2017","unstructured":"Nangia J, Wang T, Osborne C et al (2017) Effect of a scalp cooling device on alopecia in women undergoing chemotherapy for breast cancer: the SCALP Randomized Clinical Trial. JAMA 317:596\u2013605. https:\/\/doi.org\/10.1001\/jama.2016.20939","journal-title":"JAMA"},{"key":"5169_CR5","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1046\/j.1365-2354.2003.00382.x","volume":"12","author":"C Macduff","year":"2003","unstructured":"Macduff C, Mackenzie T, Hutcheon A et al (2003) The effectiveness of scalp cooling in preventing alopecia for patients receiving epirubicin and docetaxel. Eur J Cancer Care (Engl) 12:154\u2013161","journal-title":"Eur J Cancer Care (Engl)"},{"key":"5169_CR6","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s00520-002-0375-y","volume":"10","author":"C Proti\u00e8re","year":"2002","unstructured":"Proti\u00e8re C, Evans K, Camerlo J et al (2002) Efficacy and tolerance of a scalp-cooling system for prevention of hair loss and the experience of breast cancer patients treated by adjuvant chemotherapy. Support Care Cancer 10:529\u2013537. https:\/\/doi.org\/10.1007\/s00520-002-0375-y","journal-title":"Support Care Cancer"},{"key":"5169_CR7","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1001\/jama.2016.21038","volume":"317","author":"HS Rugo","year":"2017","unstructured":"Rugo HS, Klein P, Melin SA et al (2017) Association between use of a scalp cooling device and alopecia after chemotherapy for breast cancer. JAMA 317:606\u2013614. https:\/\/doi.org\/10.1001\/jama.2016.21038","journal-title":"JAMA"},{"key":"5169_CR8","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1002\/pon.1615","volume":"19","author":"CJG Hurk van den","year":"2009","unstructured":"van den Hurk CJG, Mols F, Vingerhoets AJJM, Breed WPM (2009) Impact of alopecia and scalp cooling on the well-being of breast cancer patients. Psychooncology 19:701\u2013709. https:\/\/doi.org\/10.1002\/pon.1615","journal-title":"Psychooncology"},{"key":"5169_CR9","unstructured":"(2009) Oxford Centre for Evidence-based Medicine \u2013 Levels of Evidence. https:\/\/www.cebm.net\/2009\/06\/oxford-centre-evidence-based-medicine-levels-evidence-march-2009\/"},{"key":"5169_CR10","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J et al (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6:e1000097. https:\/\/doi.org\/10.1371\/journal.pmed.1000097","journal-title":"PLoS Med"},{"issue":"10","key":"5169_CR11","first-page":"477","volume":"78","author":"F Bitto","year":"2018","unstructured":"Bitto F, K\u00f6nig A, Phan-Brehm T et al (2018) Evaluation of the patient\u2019s satisfaction using a scalp cooling (SC) device to prevent chemotherapy-induced alopecia in Breast Cancer (BC) patients. Geburtshilfe Frauenheilkd 78(10):477","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"5169_CR12","doi-asserted-by":"publisher","unstructured":"Carla F, Vassalli L, Pedersini R et al (2017) Efficacy and patient acceptability of the DigniCaP ScalpCooler to prevent hair loss in breast cancer patients receiving adjuvant chemotherapy. Ann Oncol 28:. https:\/\/doi.org\/10.1093\/annonc\/mdx438.010","DOI":"10.1093\/annonc\/mdx438.010"},{"key":"5169_CR13","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.breast.2018.07.006","volume":"41","author":"A Chan","year":"2018","unstructured":"Chan A, Bauwens A, Pontre S et al (2018) Efficacy of scalp cooling in reducing alopecia in early breast cancer patients receiving contemporary chemotherapy regimens. Breast Edinb Scotl 41:127\u2013132. https:\/\/doi.org\/10.1016\/j.breast.2018.07.006","journal-title":"Breast Edinb Scotl"},{"key":"5169_CR14","doi-asserted-by":"publisher","first-page":"P5-11-17","DOI":"10.1158\/1538-7445.SABCS16-P5-11-17","volume":"77","author":"T Cigler","year":"2017","unstructured":"Cigler T, Melin S, Klein P et al (2017) Body image in women with breast cancer using a scalp cooling system to reduce chemotherapy induced alopecia. Cancer Res 77:P5-11-17. https:\/\/doi.org\/10.1158\/1538-7445.SABCS16-P5-11-17","journal-title":"Cancer Res"},{"issue":"15_suppl","key":"5169_CR15","doi-asserted-by":"crossref","first-page":"e13539","DOI":"10.1200\/jco.2009.27.15_suppl.e13539","volume":"27","author":"R El-saka","year":"2009","unstructured":"El-saka R, El-Husseiny G, Rostom Y, Salama A (2009) Scalp cooler efficacy to reduce anthracycline-induced alopecia and its QOL impact in breast cancer. J Clin Oncol. 27(15_suppl): e13539","journal-title":"J Clin Oncol"},{"key":"5169_CR16","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx424.037","author":"T Prochilo","year":"2017","unstructured":"Prochilo T, Aroldi F, Huscher A et al (2017) Hair loss prevention by scalp cooling device in early breast cancer patients: the Poliambulanza experience. Ann Oncol. https:\/\/doi.org\/10.1093\/annonc\/mdx424.037","journal-title":"Ann Oncol"},{"key":"5169_CR17","doi-asserted-by":"publisher","first-page":"e21692","DOI":"10.1200\/JCO.2016.34.15_suppl.e21692","volume":"34","author":"D Schaffrin-Nabe","year":"2016","unstructured":"Schaffrin-Nabe D, Voigtmann R, Josten-Nabe A et al (2016) Hair-mass-index (HMI) as indicator for the efficacy of scalp cooling (SC) and the associated quality of life (EORTC QLQ C30). J Clin Oncol 34:e21692\u2013e21692. https:\/\/doi.org\/10.1200\/JCO.2016.34.15_suppl.e21692","journal-title":"J Clin Oncol"},{"key":"5169_CR18","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/00002820-200601000-00006","volume":"29","author":"M Browall","year":"2006","unstructured":"Browall M, Gaston-Johansson F, Danielson E (2006) Postmenopausal women with breast cancer: their experiences of the chemotherapy treatment period. Cancer Nurs 29:34\u201342","journal-title":"Cancer Nurs"},{"key":"5169_CR19","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1200\/JCO.1996.14.10.2756","volume":"14","author":"MA Sprangers","year":"1996","unstructured":"Sprangers MA, Groenvold M, Arraras JI et al (1996) The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol 14:2756\u20132768. https:\/\/doi.org\/10.1200\/JCO.1996.14.10.2756","journal-title":"J Clin Oncol"},{"key":"5169_CR20","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1001\/jama.2016.21039","volume":"317","author":"DL Hershman","year":"2017","unstructured":"Hershman DL (2017) Scalp cooling to prevent chemotherapy-induced alopecia: the time has come. JAMA 317:587\u2013588. https:\/\/doi.org\/10.1001\/jama.2016.21039","journal-title":"JAMA"},{"key":"5169_CR21","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1093\/annonc\/mdt476","volume":"25","author":"J Cho","year":"2014","unstructured":"Cho J, Choi E, Kim I et al (2014) Development and validation of Chemotherapy-induced Alopecia Distress Scale (CADS) for breast cancer patients. Ann Oncol 25:346\u2013351. https:\/\/doi.org\/10.1093\/annonc\/mdt476","journal-title":"Ann Oncol"},{"key":"5169_CR22","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/pon.1245","volume":"17","author":"J Lemieux","year":"2008","unstructured":"Lemieux J, Maunsell E, Provencher L (2008) Chemotherapy-induced alopecia and effects on quality of life among women with breast cancer: a literature review. Psychooncology 17:317\u2013328. https:\/\/doi.org\/10.1002\/pon.1245","journal-title":"Psychooncology"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-019-05169-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-019-05169-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-019-05169-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T17:36:30Z","timestamp":1606584990000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-019-05169-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,26]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["5169"],"URL":"https:\/\/doi.org\/10.1007\/s10549-019-05169-0","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,26]]},"assertion":[{"value":"5 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Lacouture has a consultant\/speaking role with Legacy Healthcare Services, Adgero Bio Pharmaceuticals, Amryt Pharmaceuticals, Celldex Therapeutics, Debiopharm, Galderma Research and Development, Johnson and Johnson, Novocure Inc, Lindi, Merck Sharp and Dohme Corporation, Helsinn Healthcare SA, Janssen Research & Development LLC, Menlo Therapeutics, Novartis Pharmaceuticals Corporation, F. Hoffmann-La Roche AG, AbbVie Inc, Boehringer Ingelheim Pharma Gmbh & Co. KG, Allergan Inc, Amgen Inc, E.R. Squibb & Sons LLC, EMD Serono Inc, Astrazeneca Pharmaceuticals LP, Genentech Inc, Leo Pharma Inc, Seattle Genetics, Bayer, Manner SAS, Lutris, Pierre Fabre, Paxman Coolers, Adjucare, Dignitana, Biotechspert, Teva Mexico, Parexel, OnQuality Pharmaceuticals Ltd, Novartis, Harborside, Wiley, and Takeda Millenium. Dr. Lacouture also receives research funding from Berg, Bristol-Myers Squibb, Lutris, Paxman, Novocure, US Biotest, and Veloce, and is funded in part through the NIH\/NCI Cancer Center Support Grant P30 CA008748. Mr. Marks declares that he has no conflict of interest. Dr. Okhovat declares that he has no conflict of interest. Ms. Hagigeorges declares that she has no conflict of interest. Ms. Manatis-Lornell declares that she has no conflict of interest. Dr. Isakoff declares that he has no conflict of interest. Dr. Senna declares that she has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"As this study was a systematic review and did not involve contact with patients or patient information, it was not applicable for Informed consent to be obtained.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}}]}}